SUNSHINE BIOPHARMA INC. (SBFM)

Every figure this model derived for SBFM, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 19,145 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 13,748,301 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 30,665,427 AssetsCurrent 2026-06-30
current liabilities 5,619,079 LiabilitiesCurrent 2026-06-30
equity 27,538,002 StockholdersEquity 2026-06-30
interest expense 0 InterestExpenseNonoperating 2025-12-31
ocf -5,352,750 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 35,346,772 Revenues 2026-06-30
sbc 0 ShareBasedCompensation 2020-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up SBFM on one particular measure came for.

RatioValue
cash operating margin-15.66
current ratio5.46
current ratio reported5.46
dilution pct493.11
fcf margin-15.2
growth cv1.32
operating margin-16.65
owner earnings margin-15.2
revenue growth-2.74
revenue growth per share-83.6
roic-33.72
rule of 40-19.39
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about SBFM's figures. Written by the derivation as it ran, not added afterwards.